- Home
- LPSN vs PDSB Comparison
LPSN vs PDSB Comparison
Compare LPSN & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPSN
- PDSB
- Stock Information
- Founded
- LPSN 1995
- PDSB 2005
- Country
- LPSN United States
- PDSB United States
- Employees
- LPSN N/A
- PDSB N/A
- Industry
- LPSN EDP Services
- PDSB Biotechnology: Pharmaceutical Preparations
- Sector
- LPSN Technology
- PDSB Health Care
- Exchange
- LPSN Nasdaq
- PDSB Nasdaq
- Market Cap
- LPSN 72.8M
- PDSB 72.2M
- IPO Year
- LPSN 2000
- PDSB N/A
- Fundamental
- Price
- LPSN $0.74
- PDSB $1.62
- Analyst Decision
- LPSN Hold
- PDSB Strong Buy
- Analyst Count
- LPSN 3
- PDSB 2
- Target Price
- LPSN $1.20
- PDSB $10.00
- AVG Volume (30 Days)
- LPSN 833.9K
- PDSB 888.3K
- Earning Date
- LPSN 07-30-2025
- PDSB 08-12-2025
- Dividend Yield
- LPSN N/A
- PDSB N/A
- EPS Growth
- LPSN N/A
- PDSB N/A
- EPS
- LPSN N/A
- PDSB N/A
- Revenue
- LPSN $292,025,000.00
- PDSB N/A
- Revenue This Year
- LPSN N/A
- PDSB N/A
- Revenue Next Year
- LPSN $0.82
- PDSB N/A
- P/E Ratio
- LPSN N/A
- PDSB N/A
- Revenue Growth
- LPSN N/A
- PDSB N/A
- 52 Week Low
- LPSN $0.53
- PDSB $0.85
- 52 Week High
- LPSN $2.08
- PDSB $4.42
- Technical
- Relative Strength Index (RSI)
- LPSN 45.79
- PDSB 54.15
- Support Level
- LPSN $0.68
- PDSB $1.53
- Resistance Level
- LPSN $0.79
- PDSB $1.85
- Average True Range (ATR)
- LPSN 0.05
- PDSB 0.14
- MACD
- LPSN 0.00
- PDSB -0.01
- Stochastic Oscillator
- LPSN 40.29
- PDSB 44.86
About LPSN LivePerson Inc.
LivePerson Inc is the enterprise leader in digital customer conversation. The Conversational Cloud, the Company's enterprise-class digital customer conversation platform, is trusted by the world's top brands to accelerate their contact center transformation, orchestrate conversations across all channels, departments, and systems, increase agent productivity, and deliver more personalized, AI-empowered customer experiences. The company has a presence in the United Kingdom, Asia-Pacific, Latin America, and Europe.
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.